Literature DB >> 11956904

Present status of the diagnosis and treatment of gallbladder carcinoma.

J H Donohue1.   

Abstract

Because early carcinoma of the gallbladder causes no specific signs or symptoms, most patients with this disease are diagnosed with advanced-stage tumors. High-resolution ultrasonography and a low index of suspicion for polypoid masses or asymmetric gallbladder thickening represent the best method of early detection. Despite regular preoperative gallbladder imaging, many cancers are only detected intraoperatively or incidentally on pathologic examination. All known or suspected gallbladder cancers should be definitively treated with a laparotomy, not laparoscopic surgery. For early gallbladder cancers (Tis and T1 cancers), simple cholecystectomy is adequate therapy. More advanced-stage carcinomas without distant metastases should routinely be managed with a radical cholecystectomy, which includes partial hepatectomy and regional lymphadenectomy. Any adherent organs should be resected en bloc with the cancer. Pancreatoduodenectomy has been performed in several Japanese centers, but is rarely performed in the West for locally advanced gallbladder cancers. Most patients who undergo curative resection will develop recurrent disease, but there is currently no proven effective adjuvant therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11956904     DOI: 10.1007/s005340100021

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  30 in total

1.  Postoperative chemoradiotherapy for gallbladder cancer.

Authors:  K Kim; E K Chie; J-Y Jang; S W Kim; S-W Han; D-Y Oh; S-A Im; T-Y Kim; Y-J Bang; S W Ha
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

2.  Invasion of the hepatic artery is a crucial predictor of poor outcomes in gallbladder carcinoma.

Authors:  Akihiko Kobayashi; Tatsuya Oda; Kiyoshi Fukunaga; Ryoko Sasaki; Nobuhiro Ohkohchi
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

3.  Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.

Authors:  Woo Seok Kim; Dong Wook Choi; Dong Do You; Chuan Yu Ho; Jin Seok Heo; Seong Ho Choi
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

4.  Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hironori Kobayashi; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

Review 5.  Gallbladder carcinoma incidentally encountered during laparoscopic cholecystectomy: how to deal with it.

Authors:  Ketao Jin; Huanrong Lan; Tieming Zhu; Kuifeng He; Lisong Teng
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

6.  Combined extrahepatic bile duct resection for locally advanced gallbladder carcinoma: does it work?

Authors:  Tsuyoshi Igami; Tomoki Ebata; Yukihiro Yokoyama; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Yoshie Shimoyama; Masato Nagino
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

7.  Metastasis of primary gallbladder carcinoma in lymph node and liver.

Authors:  Han-Ting Lin; Gui-Jie Liu; Dan Wu; Jian-Ying Lou
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

8.  Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target.

Authors:  Mitsutsune Washiro; Masayuki Ohtsuka; Fumio Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Takashi Sugimoto; Naohiko Seki; Masaru Miyazaki
Journal:  J Cancer Res Clin Oncol       Date:  2008-01-17       Impact factor: 4.553

9.  miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.

Authors:  Pablo Letelier; Patricia García; Pamela Leal; Héctor Álvarez; Carmen Ili; Jaime López; Jonathan Castillo; Priscilla Brebi; Juan Carlos Roa
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

10.  Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro.

Authors:  Patricia Garcia; Pamela Leal; Carmen Ili; Priscilla Brebi; Hector Alvarez; Juan C Roa
Journal:  Int J Exp Pathol       Date:  2013-04-18       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.